by Fabio Giuseppe Carlo Carisio for VT Italy
US President Donald Trump revealed Friday that Gilead Sciences’ antiviral drug Remdesivir has been cleared by the Food and Drug Administration (FDA) for the treatment of COVID-19.
According to Reuters, Gilead CEO Daniel O’Day called the FDA’s emergency authorization an “important first step” and pledged to donate “1 million vials of Remdesivir.” US Vice President Mike Pence also said that 1 million vials of Remdesivir will be distributed to hospitals starting Monday.
The FDA authorization comes just two days after Gilead Sciences revealed it was aware of “positive data” from a clinical trial by the US National Institute of Allergy and Infectious Diseases of the antiviral drug as a COVID-19 treatment.
The institute is led by Anthony Fauci, one of the leading doctors assigned to the White House Coronavirus Task Force. During a Wednesday meeting in the Oval Office, Fauci indicated that the drug trial showed that Remdesivir has had a significant effect on reducing coronavirus symptoms.